VTR · Ventas, Inc. · Financials

$86.85 +1.47 (+1.72%)

S&P 500 member Russell 1000 member Rebalance outlook locked

Market Cap

$43.97B

512.95M

Volume · Oct 22 272.47K Avg daily vol (3M) 3.57M

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →

Revenue

$5.83B +18.5%

FY2025

Net Income

$261.52M +196%

FY2025

Diluted EPS

$0.54 +184.2%

FY2025

Operating Cash Flow

$1.65B +23.8%

FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow Adjusted All Metrics

Annual Quarterly

Line Item	3Y	5Y	10Y	FY2026 (G)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009	FY2008	FY2007
Revenue	+12.2%	+9.0%	+5.9%	—	$6.44B	$5.83B	$4.92B	$4.5B	$4.13B	$3.83B	$3.8B	$3.87B	$3.75B	$3.57B	$3.44B	$3.29B	$2.78B	$2.52B	$2.47B	$1.73B	$1B	$923.47M	$919.15M	$746.7M
Interest & Dividend Income	-22.3%	-22.4%	—	—	—	$22.59M	$9.06M	$22.95M	$48.16M	$74.98M	$80.51M	$89.2M	$124.22M	$117.61M	—	—	—	—	—	—	—	—	—	—
Rental Income	+2.3%	0.0%	+1.1%	—	$1.45B	$1.5B	$1.5B	$1.49B	$1.4B	$1.45B	$1.49B	$1.61B	$1.51B	$1.59B	$1.48B	$1.35B	$1.14B	$1.04B	$1.18B	$793.8M	$523.34M	$488.46M	$476.82M	—
Rental Operating Expenses	+14.5%	+12.0%	+9.4%	—	$3.85B	$3.41B	$2.82B	$2.56B	$2.28B	$2.08B	$1.94B	$1.81B	$1.69B	$1.48B	$1.43B	$1.38B	$1.2B	$1.11B	$966.42M	$645.08M	$315.95M	$302.81M	$306.94M	$198.13M
General & Administrative	+7.0%	+6.4%	+3.3%	—	$191.13M	$177.4M	$162.99M	$148.88M	$144.87M	$129.76M	$130.16M	$158.73M	$145.98M	$135.49M	$126.88M	$128.04M	$121.74M	$115.08M	$98.51M	$74.54M	$49.83M	$38.83M	$40.65M	$36.43M
Depreciation & Amortization	+4.8%	+4.4%	+4.4%	—	$1.5B	$1.38B	$1.25B	$1.39B	$1.2B	$1.2B	$1.11B	$1.05B	$919.64M	$887.95M	$898.92M	$894.06M	$725.22M	$629.91M	$714.97M	$444.19M	$200.68M	$197.3M	$229.5M	$226.52M
Impairment of Real Estate	—	—	—	—	—	—	—	—	—	—	$0	$0	$52.51M	$4.62M	$0	$42.2M	$56.6M	$51.5M	$35.6M	—	—	—	—	—
Total Costs & Expenses	+10.1%	+8.7%	+6.7%	—	$6.23B	$5.63B	$4.93B	$4.61B	$4.22B	$3.99B	$3.71B	$3.51B	$3.36B	$2.99B	$2.93B	$2.93B	$2.43B	$2.15B	$2.19B	$1.4B	$777.76M	$731.9M	$781.62M	$636.34M
Interest Expense	+9.4%	+5.5%	+5.2%	—	$628.77M	$612.25M	$602.84M	$574.11M	$467.56M	$440.09M	$469.54M	$451.66M	$442.5M	$448.2M	$419.74M	$367.11M	$292.07M	$249.01M	$288.72M	$223.8M	$172.47M	$173.81M	$202.62M	$196.66M
Other Non-Operating Income	—	—	—	—	—	—	—	—	—	—	—	$17.61M	-$66.77M	-$20.05M	—	—	—	—	—	—	—	—	—	—
Equity in Earnings of Unconsolidated Entities	-46.1%	+19.5%	—	—	—	$4.47M	$1.56M	$13.63M	$28.5M	$4.97M	$1.83M	-$2.46M	-$55.03M	-$3.59M	$4.36M	-$1.24M	-$139K	-$1.75M	$1.51M	-$52K	-$664K	$0	—	—
Pretax Income	—	+20.5%	-5.3%	—	$210.38M	$204.32M	-$8M	-$115.58M	-$94.14M	-$162.39M	$80.59M	$359.42M	$384.83M	$584.71M	$518.51M	$351.68M	$350.7M	$364.18M	$283.35M	$330.47M	$222.87M	$191.57M	$137.53M	$110.36M
Income Tax	—	—	—	—	-$49.02M	-$14.15M	-$37.78M	-$9.54M	-$16.93M	$4.83M	-$96.53M	-$56.31M	-$39.95M	-$59.8M	-$31.34M	-$39.28M	-$8.73M	-$11.83M	-$6.28M	-$30.66M	$5.2M	-$1.72M	-$15.89M	-$28.04M
Net Income	—	-9.9%	-4.6%	—	$272.97M	$261.52M	$88.35M	-$30.3M	-$40.93M	$56.56M	$441.19M	$439.3M	$415.98M	$1.36B	$651.49M	$419.22M	$477M	$454.67M	$361.78M	$363.26M	$246.17M	$266.5M	$222.6M	$273.68M
Net Margin	—	—	—	—	—	4.48%	1.79%	-0.67%	-0.99%	1.48%	11.62%	11.34%	11.11%	38.08%	18.92%	12.76%	17.18%	18.07%	14.65%	20.98%	24.6%	28.86%	24.22%	36.65%
Net Income Attributable to Noncontrolling Interests	+15.9%	+37.9%	+22.1%	—	$10.24M	$10.14M	$7.2M	$10.68M	$6.52M	$7.55M	$2.04M	$6.28M	$6.51M	$4.64M	$2.26M	$1.38M	$1.23M	$1.16M	-$1.03M	-$1.23M	$3.56M	$2.87M	$2.68M	$1.7M
Net Income Available to Common Stockholders	—	-10.6%	-5.0%	—	$262.73M	$251.38M	$81.15M	-$40.97M	-$47.45M	$49.01M	$439.15M	$433.02M	$409.47M	$1.36B	$649.23M	$417.84M	$475.77M	$453.51M	$362.8M	$364.49M	$246.17M	$266.5M	—	—
Comprehensive Income	—	-10.2%	-4.7%	—	$265.03M	$245.06M	$83.39M	-$39.93M	-$19.73M	$38.84M	$419.36M	$418.2M	$425.01M	$1.38B	$599.26M	$397.16M	$469.23M	$449.81M	$364.09M	$359.69M	$253.37M	$310.12M	$186.78M	$291.76M
EPS (Basic) USD/shares	—	-14.2%	-8.0%	—	$0.55	$0.55	$0.20	-$0.10	-$0.12	$0.13	$1.18	$1.18	$1.15	$3.82	$1.88	$1.26	$1.62	$1.55	$1.24	$1.60	$1.57	$1.75	$1.59	$2.23
EPS (Diluted) USD/shares	—	-14.3%	-8.1%	$0.58 – $0.63	$0.54	$0.54^G	$0.19	-$0.10	-$0.12	$0.13	$1.17	$1.17	$1.14	$3.78	$1.86	$1.25	$1.60	$1.54	$1.23	$1.58	$1.56	$1.74	$1.59	$2.22
Shares Outstanding (Basic Avg) shares	+4.4%	+4.0%	+3.3%	—	—	455.08M	411.77M	401.81M	399.55M	382.79M	373.37M	365.98M	356.27M	355.33M	344.7M	330.31M	294.18M	292.65M	292.06M	228.45M	156.61M	152.57M	139.57M	122.6M
Shares Outstanding (Diluted Avg) shares	+4.7%	+4.2%	+3.3%	—	—	462.62M	416.37M	405.67M	403.45M	386.3M	376.5M	369.89M	359.3M	358.57M	348.39M	334.01M	296.68M	295.11M	294.49M	230.79M	157.66M	152.76M	139.91M	123.01M

Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2007–FY2025: $13.95B in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balance	As of	Amount	Source
Operating lease liabilities	2026-06-30	USD 231,210,000	10-Q filed 2026-07-30

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue

8.77×

Peer median 11.29×

EV/EBIT

—

P/E (TTM)

158.75×

Peer median 62.74×

P/FFO (FY2025)

24.63×

Peer median 20.62×

EV/Adj. EBITDA (FY2025)

24.20×

Peer medians compare against the 7 similar-size REIT - Healthcare Facilities companies (of 17 listed).

P/FFO and EV/Adj. EBITDA use the company-stated “Normalized FFO attributable to common stockholders per share” and “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

P/FFO and EV/Adj. EBITDA use the company-stated “Normalized FFO attributable to common stockholders per share” and “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Senior Living Operations	$4,276,163,000	$3,372,796,000	$2,959,219,000	$2,651,886,000	$2,270,001,000	$2,197,160,000	$2,151,533,000	$2,069,477,000
Outpatient Medical and Research Portfolio	$897,902,000	$877,591,000	$869,708,000	$803,607,000	$802,681,000	$808,302,000	$836,725,000	$783,603,000
Triple Net Leased Properties	$601,578,000	$622,054,000	$619,208,000	$598,154,000	$653,823,000	$695,265,000	$780,898,000	$740,318,000

By Geography (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
United States	$5,209,830,000	$4,366,953,000	$4,004,173,000	$3,652,327,000	$3,363,197,000	$3,381,357,000	$3,578,341,000	$3,524,875,000
Canada	$552,924,000	$526,575,000	$464,772,000	$449,091,000	$434,862,000	$389,205,000	$266,946,000	$192,350,000
United Kingdom	$71,226,000	$30,738,000	$28,882,000	$27,775,000	$29,948,000	$24,795,000	$27,463,000	$28,585,000

By Product & Service (USD)

Component	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Resident Fees and Services	$4,276,163,000	$3,372,796,000	$2,959,219,000	$2,651,886,000	$2,270,001,000	$2,197,160,000	$2,151,533,000	$2,069,477,000
Third Party Capital Management	$17,547,000	$17,359,000	$17,841,000	$26,199,000	$20,096,000	$15,191,000	$11,156,000	$13,416,000
Management Service	$15,700,000	$15,500,000	$14,700,000	$14,500,000	$12,400,000	$6,700,000	$3,400,000	$5,800,000
Ventas Fund	—	—	—	$9,900,000	—	—	—	—

Key facts CIK 740260 CUSIP 92276F100 13F (30d) 190 filings 169 filers Visit website Investor relations